Esoteric Testing Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Esoteric Testing Market: By Type (Infectious Disease Testing, Oncology Testing, Endocrinology Testing, Genetic Testing, Toxicology testing, Immunology Testing, Neurology Testing, and Other), Technology (Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay, Mass Spectrometry, Real-Time Polymerase Chain Reaction, DNA Sequencing, Flow Cytometry,    and Others), End User (Hospital-based Laboratories, Independent and Reference Laboratories),  and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Esoteric Testing Market size was valued at USD 26,397.4 million in 2021 and poised to grow at a significant CAGR of 8.3% within the forecast period of 2022-2028. Esoteric testing refers to the evaluation of specialized or particular assays that aren’t commonly carried out in traditional diagnostic settings. Esoteric testing procedures call for expert personnel since they involve the pricey and time-consuming radioimmunoassay (RIA) technology. The increased frequency of infectious diseases, more excellent knowledge about early identification utilizing specific diagnostic tests, and an aging population with accompanying increases in chronic diseases are all factors contributing to the esoteric testing market growth. Following the pandemic, the esoteric testing industry in healthcare is anticipated to expand significantly. Most market participants have concentrated on specialized testing to combat the coronavirus epidemic, which increased the importance of esoteric testing. Thus, there is an upsurge in the research and development in esoteric testing in various government and private funding institutes, which can be expected to fuel the esoteric testing market size in the foretell period. Globally, the principal objective of healthcare service providers is to add value to patients by providing high-quality medical care. Healthcare service providers are eager to adapt their business models, offer their services for fair prices, and concentrate on enhancing patient health. This has caused a significant focus on outsourcing complicated clinical tests, which has contributed to global growth trends in the esoteric testing market share. Untreated maternal infections cause eye infections that result in blindness in over 4000 newborn newborns each year worldwide. This huge burden of infectious disease requires early and precise diagnosis for further treatment. Which propels the demand for esoteric testing in the modern health care system. Thus, the huge demand is expected to boost the esoteric testing market growth in the forecast period. In spite of high esoteric testing market demand, Lack of skilled workers, and inadequate reimbursement, the environment is projected to impede market expansion in the following years somewhat.

 

Key Developments in the Esoteric Testing Market

In March 2022, the Garvan Institute of Medical Research announced the development of A single DNA test that can screen a patient’s genome for over 50 genetic neurological and neuromuscular diseases such as Huntington’s disease, muscular dystrophies, and fragile X syndrome.

In May 2021, Labcorp acquired Myriad Genetics’ autoimmune business segment.

Esoteric Testing Market

MARKET SUMMARY
-
8.3%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 8.3%
  • Largest Market– Asia Pacific
  • Fastest Growing Market– North America

Esoteric Testing Market

  • The global esoteric testing market report gives a comprehensive outlook across the globe with particular emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
  • The report on the global esoteric testing market gives historical, current, and future market sizes based on type, technology, end user, and geography.
Key Players
  • Sonic Healthcare
  • Healthscope
  • ARUP Laboratories
  • Fulgent Genetics
  • Invitae Corporation
Esoteric Testing Market Dynamics

Esoteric tests are carried out in the areas of cancer, genetic diseases, lipid disorders, diabetes, and cardiovascular diseases. A tremendous burden of infectious diseases, hospital-acquired infections, genetic diseases, cancer, and autoimmune diseases control the esoteric testing market dynamics. According to the WHO datasheet, there are at least 7 in developed countries and 10 in developing countries hospital-acquired infection globally. This high prevalence of diseases shapes the esoteric system market size in the prophecy period. A medical condition’s early diagnosis opens up the possibility of therapy and further care. Early disease detection aids in making vital medical decisions regarding care, support requirements, finances, and legal issues for both patients and medical staff, including symptom reversal, efficient, earlier, and early treatment of the person, patient empowerment, time for improved decision-making, and others. One of the most successful and often used testing methods for the detection of diseases linked to numerous medical specializations is the esoteric examination. In the years to come, the demand for esoteric testing should increase due to the increased prevalence of chronic infectious diseases, including cancer, diabetes, and other similar conditions, which can be predicted to set in motion the expansion of the esoteric testing market. Moreover, the development of esoteric testing will be accelerated over time by technical developments like antidote automation, standardization of cutting-edge instruments, and analysis systems. Proteomics and genomics are in more demand, and more capital is being invested in creating cutting-edge body detection testing methods, which will help businesses flourish. Governments nowadays put up campaigns to aware people of the advantages of early and specialized testing. One of the key factors propelling the worldwide esoteric testing market growth is the rising public awareness of the value of early disease identification.


North-America Got Significant Share

Esoteric Testing Market

Due to the rising prevalence of chronic diseases, an increase in the number of diagnostic tests, the prevalence of infectious disease, hospital-acquired infections, cancer, and technological advancements in esoteric testing, North America accounted for a significant portion of the global market for esoteric testing in 2021 and is predicted to maintain its leadership during the forecast period. But from 2022 to 2030, Asia-Pacific is predicted to have the most outstanding CAGR, at 10.5%, due to rising chronic illness incidence, increased government support for diagnostic services, soaring demand for ELISA and RT-PCR tests, and rising public awareness of the benefits of self-diagnostic testing.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The esoteric system market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and startup details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Esoteric Testing Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The esoteric testing market is projected to expand at a CAGR of 8.3% during the forecast period

Quest Diagnostics, OPKO Health, Inc., MIRACA HOLDINGS Inc., Myriad Genetics, Inc., Sonic Healthcare, Healthscope, Foundation Medicine

North America is the fastest-growing region for the esoteric testing market


Report

Table Of Content

1. Executive Summary
2. Global Esoteric Testing Market Introduction
2.1. Global Esoteric Testing Market – Taxonomy
2.2. Global Esoteric Testing Market –Definitions
2.2.1. By Type
2.2.2. By Technology
2.2.3. By End User
2.2.4. By Region
3. Global Esoteric Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Esoteric Testing Market Dynamic Factors – Impact Analysis
3.6. Global Esoteric Testing Market – Competition Landscape
3.7. Epidemiology
4. Global Esoteric Testing Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Esoteric Testing Market, By Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Infectious Disease Testing
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Oncology Testing
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Endocrinology Testing
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Genetic Testing
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Toxicology Testing
5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Immunology Testing
5.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Neurology Testing
5.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Other Testing
5.8.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
6. Global Esoteric Testing Market, By Technology, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1. Enzyme-linked Immunosorbent Assay
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Chemiluminescence Immunoassay
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Mass Spectrometry
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Real-Time Polymerase Chain Reaction
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. DNA Sequencing
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Flow Cytometry
6.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Other Technologies
6.7.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
7. Global Esoteric Testing Market Forecast, By End User, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1. Hospital-based Laboratories
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Independent and Reference Laboratories
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Esoteric Testing Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. North America
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Esoteric Testing Market – Opportunity Analysis Index, By Type, By Technology, By End User, and Region, 2022 – 2028
9. North America Esoteric Testing Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Infectious Disease Testing
9.1.2. Oncology Testing
9.1.3. Endocrinology Testing
9.1.4. Genetic Testing
9.1.5. Toxicology Testing
9.1.6. Immunology Testing
9.1.7. Neurology Testing
9.1.8. Other Testing
9.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.2.1. Enzyme-linked Immunosorbent Assay
9.2.2. Chemiluminescence Immunoassay
9.2.3. Mass Spectrometry
9.2.4. Real-Time Polymerase Chain Reaction
9.2.5. DNA Sequencing
9.2.6. Flow Cytometry
9.2.7. Other Technologies
9.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.3.1. Hospital-based Laboratories
9.3.2. Independent and Reference Laboratories
9.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.4.1. USA
9.4.2. Canada
9.5. North America Esoteric Testing Market – Opportunity Analysis Index, By Type, By Technology, By End User and Country, 2022 – 2028
9.6. North America Esoteric Testing Market Dynamics – Trends
10. Europe Esoteric Testing Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Infectious Disease Testing
10.1.2. Oncology Testing
10.1.3. Endocrinology Testing
10.1.4. Genetic Testing
10.1.5. Toxicology Testing
10.1.6. Immunology Testing
10.1.7. Neurology Testing
10.1.8. Other Testing
10.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Enzyme-linked Immunosorbent Assay
10.2.2. Chemiluminescence Immunoassay
10.2.3. Mass Spectrometry
10.2.4. Real-Time Polymerase Chain Reaction
10.2.5. DNA Sequencing
10.2.6. Flow Cytometry
10.2.7. Other Technologies
10.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.3.1. Hospital-based Laboratories
10.3.2. Independent and Reference Laboratories
10.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.4.1. Germany
10.4.2. UK
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Esoteric Testing Market – Opportunity Analysis Index, By Type, By Technology, By End User and Country, 2022 – 2028
10.6. Europe Esoteric Testing Market Dynamics – Trends
11. Asia-Pacific Esoteric Testing Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Infectious Disease Testing
11.1.2. Oncology Testing
11.1.3. Endocrinology Testing
11.1.4. Genetic Testing
11.1.5. Toxicology Testing
11.1.6. Immunology Testing
11.1.7. Neurology Testing
11.1.8. Other Testing
11.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Enzyme-linked Immunosorbent Assay
11.2.2. Chemiluminescence Immunoassay
11.2.3. Mass Spectrometry
11.2.4. Real-Time Polymerase Chain Reaction
11.2.5. DNA Sequencing
11.2.6. Flow Cytometry
11.2.7. Other Technologies
11.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.3.1. Hospital-based Laboratories
11.3.2. Independent and Reference Laboratories
11.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. ASEAN
11.4.5. Australia & New Zealand
11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Esoteric Testing Market – Opportunity Analysis Index, By Type, By Technology, By End User and Country, 2022 – 2028
11.6. Asia-Pacific Esoteric Testing Market Dynamics – Trends
12. Latin America Esoteric Testing Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Infectious Disease Testing
12.1.2. Oncology Testing
12.1.3. Endocrinology Testing
12.1.4. Genetic Testing
12.1.5. Toxicology Testing
12.1.6. Immunology Testing
12.1.7. Neurology Testing
12.1.8. Other Testing
12.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Enzyme-linked Immunosorbent Assay
12.2.2. Chemiluminescence Immunoassay
12.2.3. Mass Spectrometry
12.2.4. Real-Time Polymerase Chain Reaction
12.2.5. DNA Sequencing
12.2.6. Flow Cytometry
12.2.7. Other Technologies
12.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.3.1. Hospital-based Laboratories
12.3.2. Independent and Reference Laboratories
12.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Argentina
12.4.4. Rest of Latin America
12.5. Latin America Esoteric Testing Market – Opportunity Analysis Index, By Type, By Technology, By End User and Country, 2022 – 2028
12.6. Latin America Esoteric Testing Market Dynamics – Trends
13. Middle East and Africa Esoteric Testing Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Infectious Disease Testing
13.1.2. Oncology Testing
13.1.3. Endocrinology Testing
13.1.4. Genetic Testing
13.1.5. Toxicology Testing
13.1.6. Immunology Testing
13.1.7. Neurology Testing
13.1.8. Other Testing
13.2. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Enzyme-linked Immunosorbent Assay
13.2.2. Chemiluminescence Immunoassay
13.2.3. Mass Spectrometry
13.2.4. Real-Time Polymerase Chain Reaction
13.2.5. DNA Sequencing
13.2.6. Flow Cytometry
13.2.7. Other Technologies
13.3. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.3.1. Hospital-based Laboratories
13.3.2. Independent and Reference Laboratories
13.4. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.4.1. Gulf Cooperation Council (GCC) Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. MEA Esoteric Testing Market – Opportunity Analysis Index, By Type, By Technology, By End User and Country, 2022 – 2028
13.6. MEA Esoteric Testing Market Dynamics – Trends
14. Competition Landscape
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Quest Diagnostics
14.2.2. OPKO Health, Inc.
14.2.3. MIRACA HOLDINGS Inc.
14.2.4. Myriad Genetics, Inc.
14.2.5. Sonic Healthcare
14.2.6. Healthscope
14.2.7. Foundation Medicine
14.2.8. ACM Global Laboratories
14.2.9. ARUP Laboratories
14.2.10. Fulgent Genetics
14.2.11. Invitae Corporation
14.2.12. Mayo Foundation for Medical Education and Research
14.2.13. Fresenius Medical Care
14.2.14. Charles River Laboratories
14.2.15. Pacific Bio labs, Inc.
14.2.16. Merck KGaA
14.2.17. WuXi AppTec
14.2.18. North American Science Associates Inc
14.2.19. Nelson Laboratories, LLC
15. Research Methodology
16. Key Assumptions and Acronyms

Report

Company Profile

  • Quest Diagnostics
  • OPKO Health, Inc.
  • MIRACA HOLDINGS Inc.
  • Myriad Genetics, Inc.
  • Sonic Healthcare
  • Healthscope
  • Foundation Medicine
  • ACM Global Laboratories
  • ARUP Laboratories
  • Fulgent Genetics
  • Invitae Corporation
  • Mayo Foundation for Medical Education and Research
  • Fresenius Medical Care
  • Charles River Laboratories
  • Pacific Bio labs, Inc.
  • Merck KGaA
  • WuXi AppTec
  • North American Science Associates Inc
  • Nelson Laboratories, LLC

Description

Esoteric Testing Market size was valued at USD 26,397.4 million in 2021 and poised to grow at a significant CAGR of 8.3% within the forecast period of 2022-2028. Esoteric testing refers to the evaluation of specialized or particular assays that aren’t commonly carried out in traditional diagnostic settings. Esoteric testing procedures call for expert personnel since they involve the pricey and time-consuming radioimmunoassay (RIA) technology. The increased frequency of infectious diseases, more excellent knowledge about early identification utilizing specific diagnostic tests, and an aging population with accompanying increases in chronic diseases are all factors contributing to the esoteric testing market growth. Following the pandemic, the esoteric testing industry in healthcare is anticipated to expand significantly. Most market participants have concentrated on specialized testing to combat the coronavirus epidemic, which increased the importance of esoteric testing. Thus, there is an upsurge in the research and development in esoteric testing in various government and private funding institutes, which can be expected to fuel the esoteric testing market size in the foretell period. Globally, the principal objective of healthcare service providers is to add value to patients by providing high-quality medical care. Healthcare service providers are eager to adapt their business models, offer their services for fair prices, and concentrate on enhancing patient health. This has caused a significant focus on outsourcing complicated clinical tests, which has contributed to global growth trends in the esoteric testing market share. Untreated maternal infections cause eye infections that result in blindness in over 4000 newborn newborns each year worldwide. This huge burden of infectious disease requires early and precise diagnosis for further treatment. Which propels the demand for esoteric testing in the modern health care system. Thus, the huge demand is expected to boost the esoteric testing market growth in the forecast period. In spite of high esoteric testing market demand, Lack of skilled workers, and inadequate reimbursement, the environment is projected to impede market expansion in the following years somewhat.

 

Key Developments in the Esoteric Testing Market

In March 2022, the Garvan Institute of Medical Research announced the development of A single DNA test that can screen a patient’s genome for over 50 genetic neurological and neuromuscular diseases such as Huntington’s disease, muscular dystrophies, and fragile X syndrome.

In May 2021, Labcorp acquired Myriad Genetics’ autoimmune business segment.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX